Anti-HER3 antibodies and uses thereof

Details for Australian Patent Application No. 2010335282 (hide)

Owner Roche Glycart AG

Inventors Bossenmaier, Birgit; Dimoudis, Nikolaos; Friess, Thomas; Georges, Guy; Kolm, Irene; Krell, Hans-Willi; Lifke, Valeria; Moessner, Ekkehard

Agent Griffith Hack

Pub. Number AU-A-2010335282

PCT Pub. Number WO2011/076683

Priority 09015831.2 22.12.09 EP

Filing date 17 December 2010

Wipo publication date 30 June 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

C07K 16/32 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/076683 Priority application(s): WO2011/076683

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010335283-Sequence dependent aggregation

2010335277-Substituted benzamide derivatives